Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

AstraZeneca PLC

+ Add to Watchlist

AZN:LN

4,743.000 GBp 18.500 0.39%

As of 11:35:11 ET on 01/30/2015.

Snapshot for AstraZeneca PLC (AZN)

Open: 4,756.000 Day's Range: 4,684.500 - 4,797.000 Volume: 3,746,512
Previous Close: 4,761.500 52wk Range: 3,718.500 - 4,845.000 1-Yr Rtn: +28.09%

Stock Chart for AZN

No chart data available.
  • AZN:LN 4,743.000
  • 1D
  • 1M
  • 1Y
4,761.500
Interactive AZN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AZN

Current P/E Ratio (ttm) 88.9255
Estimated P/E(12/2014) 16.3937
Relative P/E vs. UKX 4.6545
Earnings Per Share (USD) (ttm) 0.8100
Est. EPS (USD) (12/2014) 4.3930
Est. PEG Ratio -
Market Cap (M GBP) 60,504.57
Shares Outstanding (M) 1,263.14
30 Day Average Volume 2,405,672
Price/Book (mrq) 4.4023
Price/Sale (ttm) 3.4190
Dividend Indicated Gross Yield 3.89%
Cash Dividend (USD) -
Dividend Ex-Date 02/19/2015
5 Year Dividend Growth 3.93%
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AZN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AZN

AstraZeneca PLC is a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas: Gastrointestinal, Oncology, Cardiovascular, Respiratory, Central Nervous System, Pain Control, Anaesthesia, and Infection.

Pascal SoriotChief Executive OfficerMarc DunoyerCFO/Executive Director
Shobie RamakrishnanChief Technology OfficerDavid SmoleyChief Information Officer
More Company Profile & Key Executives for AZN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil